CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models ; volume:3 ; number:1 ; day:24 ; month:2 ; year:2006 ; pages:1-10 ; date:12.2006
Journal of neuroinflammation ; 3, Heft 1 (24.2.2006), 1-10, 12.2006
- Urheber
-
Laporte, Vincent
- Beteiligte Personen und Organisationen
-
Ait-Ghezala, Ghania
Volmar, Claude-Henry
Mullan, Michael
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-3-3
- URN
-
urn:nbn:de:1111-2016032325554
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Laporte, Vincent
- Ait-Ghezala, Ghania
- Volmar, Claude-Henry
- Mullan, Michael
- SpringerLink (Online service)
Ähnliche Objekte (12)
PERK activation mitigates tau pathology in vitro and in vivo
Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex – evidence from two transgenic mouse models
Modulation of Alzheimer's pathology in transgenic mouse models
Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
Mechanismen der Aktivierung von CD40 durch monoklonale Antikörper und löslichen CD40 Liganden und der Nachweis von löslichem CD40 in vivo, einem möglichen Regulator der CD40-CD40 Ligand Interaktion
Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice
Activation of TrkB signaling mitigates cerebellar anomalies caused by Rbm4-Bdnf deficiency
IL-15 deficiency promotes tumor growth in tax transgenic mice
Deficiency of prolyl hydroxylase containing enzyme 1 mitigates colitis via increased goblet cell activity
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
PERK activation mitigates tau pathology in vitro and in vivo
Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex – evidence from two transgenic mouse models
Modulation of Alzheimer's pathology in transgenic mouse models
Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
Mechanismen der Aktivierung von CD40 durch monoklonale Antikörper und löslichen CD40 Liganden und der Nachweis von löslichem CD40 in vivo, einem möglichen Regulator der CD40-CD40 Ligand Interaktion
Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice
Activation of TrkB signaling mitigates cerebellar anomalies caused by Rbm4-Bdnf deficiency
IL-15 deficiency promotes tumor growth in tax transgenic mice
Deficiency of prolyl hydroxylase containing enzyme 1 mitigates colitis via increased goblet cell activity
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
PERK activation mitigates tau pathology in vitro and in vivo
Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex – evidence from two transgenic mouse models
Modulation of Alzheimer's pathology in transgenic mouse models
Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
Mechanismen der Aktivierung von CD40 durch monoklonale Antikörper und löslichen CD40 Liganden und der Nachweis von löslichem CD40 in vivo, einem möglichen Regulator der CD40-CD40 Ligand Interaktion
Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice
Activation of TrkB signaling mitigates cerebellar anomalies caused by Rbm4-Bdnf deficiency
IL-15 deficiency promotes tumor growth in tax transgenic mice
Deficiency of prolyl hydroxylase containing enzyme 1 mitigates colitis via increased goblet cell activity